Abstract

BackgroundGLPG0634 is an orally-available, selective Janus kinase 1 (JAK1) inhibitor. Less-selective JAK inhibitors have shown long-term efficacy in treating rheumatoid arthritis (RA) but also dose-limiting side effects. Selective inhibition of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0494 Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, Shows Similar PK and PD Profiles in Japanese and Caucasian Healthy Volunteers
F Namour ... C Tasset
Annals of the Rheumatic Diseases | VOL. 74
F Namour, et. al.F Namour ... C Tasset
01 Jun 2015
AB0460 Glpg0634, A Selective JAK1 Inhibitor, Confirms Its Low Liability for Drug-Drug Interactions
F Namour ... A Van Der Aa
Annals of the Rheumatic Diseases | VOL. 73
F Namour, et. al.F Namour ... A Van Der Aa
01 Jun 2014
THU0236 Once-Daily Dosing of GLPG0634, a Selective JAK1 Inhibitor, is Supported by Its Active Metabolite
F Namour ... R Galien
Annals of the Rheumatic Diseases | VOL. 72
F Namour, et. al.F Namour ... R Galien
01 Jun 2013
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection.
Florence Namour ... Annegret Van Der Aa
Clinical pharmacokinetics | VOL. 54
Florence Namour, et. al.Florence Namour ... Annegret Van Der Aa
14 Feb 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
Yusuke Yoshimura ... Naoki Sawa
Annals of the Rheumatic Diseases | VOL. -
Yusuke Yoshimura, et. al.Yusuke Yoshimura ... Naoki Sawa
04 Jul 2024
Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis
Katerina Kachler ... Aline Bozec
Annals of the Rheumatic Diseases | VOL. -
Katerina Kachler, et. al.Katerina Kachler ... Aline Bozec
04 Jul 2024
Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus
Amy L Roberts ... Timothy J Vyse
Annals of the Rheumatic Diseases | VOL. -
Amy L Roberts, et. al.Amy L Roberts ... Timothy J Vyse
27 Jun 2024
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis
Aiden Haghikia ... Dimitrios Mougiakakos
Annals of the Rheumatic Diseases | VOL. -
Aiden Haghikia, et. al.Aiden Haghikia ... Dimitrios Mougiakakos
27 Jun 2024
View more papers